Role of regulatory T cells in human diseases

Journal of Allergy and Clinical Immunology

Volumn 116, Issue 5, 2005, Pages 949-959

  Chatila, Talal A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allergy; Autoimmunity; Dysregulation polyendocrinopathy enteropathy X linked; Foxp3; IgE; Immunotherapy; Lymphoproliferation; Regulatory T cells; X linked autoimmunity allergic dysregulation

Indexed keywords

ALLERGEN; AUTOANTIGEN; COLECALCIFEROL; CORTICOSTEROID; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PROBIOTIC AGENT; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE IMMUNOTHERAPY; ALLERGIC DISEASE; ASTHMA; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL MATURATION; CLINICAL FEATURE; CLINICAL TRIAL; GENE MUTATION; GENETIC CODE; HUMAN; HYGIENE; HYPOTHESIS; IMMUNOLOGICAL TOLERANCE; INFECTION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MICROFLORA; MYCOBACTERIUM VACCAE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THYMUS; TIGHT JUNCTION; TRANSCRIPTIN FACTOR FOXP 3 DEFICIENCY;

EID: 27644433355     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.08.047     Document Type: Review

References (121)

1. J.A. Bluestone, and A.K. Abbas Natural versus adaptive regulatory T cells Nat Rev Immunol 3 2003 253 257
2. D.T. Umetsu, O. Akbari, and R.H. Dekruyff Regulatory T cells control the development of allergic disease and asthma J Allergy Clin Immunol 112 2003 480 488
3. S. Sakaguchi Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 2004 531 562
4. S. Read, V. Malmstrom, and F. Powrie Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation J Exp Med 192 2000 295 302
5. T. Takahashi, T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, and N. Sakaguchi Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 J Exp Med 192 2000 303 310
6. R.S. McHugh, M.J. Whitters, C.A. Piccirillo, D.A. Young, E.M. Shevach, and M. Collins CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor Immunity 16 2002 311 323
7. J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance Nat Immunol 3 2002 135 142
8. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057 1061
9. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
10. E.M. Shevach CD4+ CD25+ suppressor T cells: more questions than answers Nat Rev Immunol 2 2002 389 400
11. A.M. Thornton, and E.M. Shevach CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production J Exp Med 188 1998 287 296
12. D. Xu, H. Liu, M. Komai-Koma, C. Campbell, C. McSharry, and J. Alexander CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice J Immunol 170 2003 394 399
13. M. Stassen, H. Jonuleit, C. Muller, M. Klein, C. Richter, and T. Bopp Differential regulatory capacity of CD25+ T regulatory cells and preactivated CD25+ T regulatory cells on development, functional activation, and proliferation of Th2 cells J Immunol 173 2004 267 274
14. S. Suvas, U. Kumaraguru, C.D. Pack, S. Lee, and B.T. Rouse CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses J Exp Med 198 2003 889 901
15. H. von Boehmer Mechanisms of suppression by suppressor T cells Nat Immunol 6 2005 338 344
16. W.J. Grossman, J.W. Verbsky, W. Barchet, M. Colonna, J.P. Atkinson, and T.J. Ley Human T regulatory cells can use the perforin pathway to cause autologous target cell death Immunity 21 2004 589 601
17. E.A. Green, L. Gorelik, C.M. McGregor, E.H. Tran, and R.A. Flavell CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes Proc Natl Acad Sci U S A 100 2003 10878 10883
18. M.L. Chen, M.J. Pittet, L. Gorelik, R.A. Flavell, R. Weissleder, and H. von Boehmer Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo Proc Natl Acad Sci U S A 102 2005 419 424
19. J.C. Marie, J.J. Letterio, M. Gavin, and A.Y. Rudensky TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells J Exp Med 201 2005 1061 1067
20. M. Asano, M. Toda, N. Sakaguchi, and S. Sakaguchi Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation J Exp Med 184 1996 387 396
21. M.S. Jordan, M.P. Riley, H. von Boehmer, and A.J. Caton Anergy and suppression regulate CD4(+) T cell responses to a self peptide Eur J Immunol 30 2000 136 144
22. M.S. Jordan, A. Boesteanu, A.J. Reed, A.L. Petrone, A.E. Holenbeck, and M.A. Lerman Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide Nat Immunol 2 2001 301 306
23. K. Kawahata, Y. Misaki, M. Yamauchi, S. Tsunekawa, K. Setoguchi, and J. Miyazaki Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression J Immunol 168 2002 4399 4405
24. I. Apostolou, A. Sarukhan, L. Klein, and H. von Boehmer Origin of regulatory T cells with known specificity for antigen Nat Immunol 3 2002 756 763
25. H.M. van Santen, C. Benoist, and D. Mathis Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells J Exp Med 200 2004 1221 1230
26. J.D. Fontenot, J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky Regulatory T cell lineage specification by the forkhead transcription factor foxp3 Immunity 22 2005 329 341
27. Y.Y. Wan, and R.A. Flavell Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter Proc Natl Acad Sci U S A 102 2005 5126 5131
28. T.R. Malek, and A.L. Bayer Tolerance, not immunity, crucially depends on IL-2 Nat Rev Immunol 4 2004 665 674
29. W. Chen, W. Jin, N. Hardegen, K.J. Lei, L. Li, and N. Marinos Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med 198 2003 1875 1886
30. S.G. Zheng, J.H. Wang, J.D. Gray, H. Soucier, and D.A. Horwitz Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10 J Immunol 172 2004 5213 5221
31. M.C. Fantini, C. Becker, G. Monteleone, F. Pallone, P.R. Galle, and M.F. Neurath Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 J Immunol 172 2004 5149 5153
32. M.R. Walker, D.J. Kasprowicz, V.H. Gersuk, A. Benard, M. Van Landeghen, and J.H. Buckner Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells J Clin Invest 112 2003 1437 1443
33. H. Yagi, T. Nomura, K. Nakamura, S. Yamazaki, T. Kitawaki, and S. Hori Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells Int Immunol 16 2004 1643 1656
34. I. Apostolou, and H. von Boehmer In vivo instruction of suppressor commitment in naive T cells J Exp Med 199 2004 1401 1408
35. D. Mucida, N. Kutchukhidze, A. Erazo, M. Russo, J.J. Lafaille, and M.A. Curotto de Lafaille Oral tolerance in the absence of naturally occurring Tregs J Clin Invest 115 2005 1923 1933
36. R. Khattri, D. Kasprowicz, T. Cox, M. Mortrud, M.W. Appleby, and M.E. Brunkow The amount of scurfin protein determines peripheral T cell number and responsiveness J Immunol 167 2001 6312 6320
37. V.L. Godfrey, J.E. Wilkinson, and L.B. Russell X-linked lymphoreticular disease in the scurfy (sf) mutant mouse Am J Pathol 138 1991 1379 1387
38. M.F. Lyon, J. Peters, P.H. Glenister, S. Ball, and E. Wright The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome Proc Natl Acad Sci U S A 87 1990 2433 2437
39. J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nat Immunol 4 2003 330 336
40. W. Lin, N. Truong, W.J. Grossman, D. Haribhai, C.B. Williams, and J. Wang Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice J Allergy Clin Immunol 116 2005 1106 1115
41. M.A. Curotto de Lafaille, S. Muriglan, M.J. Sunshine, Y. Lei, N. Kutchukhidze, and G.C. Furtado Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes J Exp Med 194 2001 1349 1359
42. M.E. Brunkow, E.W. Jeffery, K.A. Hjerrild, B. Paeper, L.B. Clark, and S.A. Yasayko Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse Nat Genet 27 2001 68 73
43. T.A. Chatila, F. Blaeser, N. Ho, H.M. Lederman, C. Voulgaropoulos, and C. Helms JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome J Clin Invest 106 2000 R75 R81
44. R.S. Wildin, F. Ramsdell, J. Peake, F. Faravelli, J.L. Casanova, and N. Buist X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy Nat Genet 27 2001 18 20
45. C.L. Bennett, J. Christie, F. Ramsdell, M.E. Brunkow, P.J. Ferguson, and L. Whitesell The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Nat Genet 27 2001 20 21
46. R.S. Wildin, S. Smyk-Pearson, and A.H. Filipovich Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome J Med Genet 39 2002 537 545
47. H.D. Ochs, S.F. Ziegler, and T.R. Torgerson FOXP3 acts as a rheostat of the immune response Immunol Rev 203 2005 156 164
48. D.S. Nieves, R.P. Phipps, S.J. Pollock, H.D. Ochs, Q. Zhu, and G.A. Scott Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome Arch Dermatol 140 2004 466 472
49. O. Baud, O. Goulet, D. Canioni, F. Le Deist, I. Radford, and D. Rieu Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation N Engl J Med 344 2001 1758 1762
50. S. Shenoy, W.J. Grossman, J. DiPersio, L.C. Yu, D. Wilson, and Y.J. Barnes A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders Bone Marrow Transplant 35 2005 345 352
51. B. Wang, D. Lin, C. Li, and P. Tucker Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors J Biol Chem 278 2003 24259 24268
52. S. Li, J. Weidenfeld, and E.E. Morrisey Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions Mol Cell Biol 24 2004 809 822
53. L.A. Schubert, E. Jeffery, Y. Zhang, F. Ramsdell, and S.F. Ziegler Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation J Biol Chem 276 2001 37672 37679
54. E. Bettelli, M. Dastrange, and M. Oukka Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells Proc Natl Acad Sci U S A 102 2005 5138 5143
55. L.B. Clark, M.W. Appleby, M.E. Brunkow, J.E. Wilkinson, S.F. Ziegler, and F. Ramsdell Cellular and molecular characterization of the scurfy mouse mutant J Immunol 162 1999 2546 2554
56. P.J. Blair, S.J. Bultman, J.C. Haas, B.T. Rouse, J.E. Wilkinson, and V.L. Godfrey CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse J Immunol 153 1994 3764 3774
57. R. Khattri, T. Cox, S.A. Yasayko, and F. Ramsdell An essential role for Scurfin in CD4+CD25+ T regulatory cells Nat Immunol 4 2003 337 342
58. T. Naka, H. Tsutsui, M. Fujimoto, Y. Kawazoe, H. Kohzaki, and Y. Morita SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo Immunity 14 2001 535 545
59. J.D. Gorham, J.T. Lin, J.L. Sung, L.A. Rudner, and M.A. French Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis J Immunol 166 2001 6413 6422
60. C.J. Owen, C.E. Jennings, H. Imrie, A. Lachaux, N.A. Bridges, and T.D. Cheetham Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome J Clin Endocrinol Metab 88 2003 6034 6039
61. T.R. Malek, A. Yu, V. Vincek, P. Scibelli, and L. Kong CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2 Immunity 17 2002 167 178
62. R.H. Buckley Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution Annu Rev Immunol 22 2004 625 655
63. B. Sadlack, J. Lohler, H. Schorle, G. Klebb, H. Haber, and E. Sickel Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells Eur J Immunol 25 1995 3053 3059
64. B. Sadlack, H. Merz, H. Schorle, A. Schimpl, A.C. Feller, and I. Horak Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene Cell 75 1993 253 261
65. D.M. Willerford, J. Chen, J.A. Ferry, L. Davidson, A. Ma, and F.W. Alt Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment Immunity 3 1995 521 530
66. H. Suzuki, T.M. Kundig, C. Furlonger, A. Wakeham, E. Timms, and T. Matsuyama Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta Science 268 1995 1472 1476
67. J.W. Snow, N. Abraham, M.C. Ma, B.G. Herndier, A.W. Pastuszak, and M.A. Goldsmith Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice J Immunol 171 2003 5042 5050
68. M. Wolf, A. Schimpl, and T. Hunig Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms Eur J Immunol 31 2001 1637 1645
69. N. Sharfe, H.K. Dadi, M. Shahar, and C.M. Roifman Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor Proc Natl Acad Sci U S A 94 1997 3168 3171
70. C.M. Roifman Human IL-2 receptor alpha chain deficiency Pediatr Res 48 2000 6 11
71. R.J. Greenwald, G.J. Freeman, and A.H. Sharpe The B7 family revisited Annu Rev Immunol 23 2005 515 548
72. E.A. Tivol, F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4 Immunity 3 1995 541 547
73. P. Waterhouse, J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, and K.P. Lee Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 Science 270 1995 985 988
74. B. Vaidya, and S. Pearce The emerging role of the CTLA-4 gene in autoimmune endocrinopathies Eur J Endocrinol 150 2004 619 626
75. G. Menasche, J. Feldmann, A. Fischer, and G. de Saint Basile Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis Immunol Rev 203 2005 165 179
76. A. O'Garra, P.L. Vieira, P. Vieira, and A.E. Goldfeld IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage J Clin Invest 114 2004 1372 1378
77. R. Bacchetta, M. Bigler, J.L. Touraine, R. Parkman, P.A. Tovo, and J. Abrams High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells J Exp Med 179 1994 493 502
78. H. Groux, A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, and J.E. de Vries A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis Nature 389 1997 737 742
79. M.K. Levings, R. Sangregorio, F. Galbiati, S. Squadrone, R. de Waal Malefyt, and M.G. Roncarolo IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells J Immunol 166 2001 5530 5539
80. F.J. Barrat, D.J. Cua, A. Boonstra, D.F. Richards, C. Crain, and H.F. Savelkoul In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines J Exp Med 195 2002 603 616
81. P.L. Vieira, J.R. Christensen, S. Minaee, E.J. O'Neill, F.J. Barrat, and A. Boonstra IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells J Immunol 172 2004 5986 5993
82. Y. Chen, V.K. Kuchroo, J. Inobe, D.A. Hafler, and H.L. Weiner Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis Science 265 1994 1237 1240
83. H.L. Weiner Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells Immunol Rev 182 2001 207 214
84. C. Karagiannidis, M. Akdis, P. Holopainen, N.J. Woolley, G. Hense, and B. Ruckert Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma J Allergy Clin Immunol 114 2004 1425 1433
85. F. Cottrez, and H. Groux Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells Transplantation 77 suppl 2004 S12 S15
86. A. Foussat, F. Cottrez, V. Brun, N. Fournier, J.P. Breittmayer, and H. Groux A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation J Immunol 171 2003 5018 5026
87. L. Cosmi, F. Liotta, E. Lazzeri, M. Francalanci, R. Angeli, and B. Mazzinghi Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes Blood 102 2003 4107 4114
88. J.S. Manavalan, S. Kim-Schulze, L. Scotto, A.J. Naiyer, G. Vlad, and P.C. Colombo Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity Int Immunol 16 2004 1055 1068
89. E. Xystrakis, A.S. Dejean, I. Bernard, P. Druet, R. Liblau, and D. Gonzalez-Dunia Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation Blood 104 2004 3294 3301
90. J. Liu, Z. Liu, P. Witkowski, G. Vlad, J.S. Manavalan, and L. Scotto Rat CD8(+) FOXP3(+) T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection Transpl Immunol 13 2004 239 247
91. M.R. Karlsson, J. Rugtveit, and P. Brandtzaeg Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy J Exp Med 199 2004 1679 1688
92. L.S. Ou, E. Goleva, C. Hall, and D.Y. Leung T regulatory cells in atopic dermatitis and subversion of their activity by superantigens J Allergy Clin Immunol 113 2004 756 763
93. J.N. Francis, S.J. Till, and S.R. Durham Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy J Allergy Clin Immunol 111 2003 1255 1261
94. M. Jutel, M. Akdis, F. Budak, C. Aebischer-Casaulta, M. Wrzyszcz, and K. Blaser IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy Eur J Immunol 33 2003 1205 1214
95. M. Akdis, J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, and R. Crameri Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells J Exp Med 199 2004 1567 1575
96. X. Dao Nguyen, and D.S. Robinson Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism J Allergy Clin Immunol 114 2004 296 301
97. C. Zuany-Amorim, E. Sawicka, C. Manlius, A. Le Moine, L.R. Brunet, and D.M. Kemeny Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells Nat Med 8 2002 625 629
98. C. Zuany-Amorim, C. Manlius, A. Trifilieff, L.R. Brunet, G. Rook, and G. Bowen Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation J Immunol 169 2002 1492 1499
99. C. Ozdemir, T. Akkoc, N.N. Bahceciler, D. Kucukercan, I.B. Barlan, and M.M. Basaran Impact of Mycobacterium vaccae immunization on lung histopathology in a murine model of chronic asthma Clin Exp Allergy 33 2003 266 270
100. P.D. Arkwright, and T.J. David Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease J Allergy Clin Immunol 107 2001 531 534
101. L. Camporota, A. Corkhill, H. Long, J. Lordan, L. Stanciu, and N. Tuckwell The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma Eur Respir J 21 2003 287 293
102. P.M. Shirtcliffe, A. Goldkorn, M. Weatherall, P.L. Tan, and R. Beasley Pilot study of the safety and effect of intranasal delipidated acid-treated Mycobacterium vaccae in adult asthma Respirology 8 2003 497 503
103. J.J. Smit, H. Van Loveren, M.O. Hoekstra, M.A. Schijf, G. Folkerts, and F.P. Nijkamp Mycobacterium vaccae administration during allergen sensitization or challenge suppresses asthmatic features Clin Exp Allergy 33 2003 1083 1089
104. S. Akira, K. Takeda, and T. Kaisho Toll-like receptors: critical proteins linking innate and acquired immunity Nat Immunol 2 2001 675 680
105. I. Caramalho, T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide J Exp Med 197 2003 403 411
106. C. Pasare, and R. Medzhitov Toll-like receptors: balancing host resistance with immune tolerance Curr Opin Immunol 15 2003 677 682
107. C. Baecher-Allan, and D.A. Hafler Suppressor T cells in human diseases J Exp Med 200 2004 273 276
108. V. Viglietta, C. Baecher-Allan, H.L. Weiner, and D.A. Hafler Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis J Exp Med 199 2004 971 979
109. M.A. Kriegel, T. Lohmann, C. Gabler, N. Blank, J.R. Kalden, and H.M. Lorenz Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II J Exp Med 199 2004 1285 1291
110. A. Balandina, S. Lecart, P. Dartevelle, A. Saoudi, and S. Berrih-Aknin Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis Blood 105 2005 735 741
111. M.R. Ehrenstein, J.G. Evans, A. Singh, S. Moore, G. Warnes, and D.A. Isenberg Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy J Exp Med 200 2004 277 285
112. D. Cao, V. Malmstrom, C. Baecher-Allan, D. Hafler, L. Klareskog, and C. Trollmo Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis Eur J Immunol 33 2003 215 223
113. D. Cao, R. van Vollenhoven, L. Klareskog, C. Trollmo, and V. Malmstrom CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease Arthritis Res Ther 6 2004 R335 R346
114. B.J. Prakken, R. Samodal, T.D. Le, F. Giannoni, G.P. Yung, and J. Scavulli Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis Proc Natl Acad Sci U S A 101 2004 4228 4233
115. B.T. Rouse, and S. Suvas Regulatory cells and infectious agents: detentes cordiale and contraire J Immunol 173 2004 2211 2215
116. Y. Belkaid, and B.T. Rouse Natural regulatory T cells in infectious disease Nat Immunol 6 2005 353 360
117. R. Cabrera, Z. Tu, Y. Xu, R.J. Firpi, H.R. Rosen, and C. Liu An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection Hepatology 40 2004 1062 1071
118. J.L. Coombes, N.J. Robinson, K.J. Maloy, H.H. Uhlig, and F. Powrie Regulatory T cells and intestinal homeostasis Immunol Rev 204 2005 184 194
119. H. Hisaeda, Y. Maekawa, D. Iwakawa, H. Okada, K. Himeno, and K. Kishihara Escape of malaria parasites from host immunity requires CD4+ CD25+ regulatory T cells Nat Med 10 2004 29 30
120. Y. Yamano, N. Takenouchi, H.C. Li, U. Tomaru, K. Yao, and C.W. Grant Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease J Clin Invest 115 2005 1361 1368
121. K. Oswald-Richter, S.M. Grill, N. Shariat, M. Leelawong, M.S. Sundrud, and D.W. Haas HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells PLoS Biol 2 2004 E198